mirview mets2 64-microrna microarray assay (Rosetta Genomics)
90
Structured Review
Rosetta Genomics
mirview mets2 64-microrna microarray assay
Mirview Mets2 64 Microrna Microarray Assay, supplied by Rosetta Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirview+mets2+64-microrna+microarray+assay/mirview+mets/pm23124598-30-13-20
Average 90 stars, based on 1 article reviews
Mirview Mets2 64 Microrna Microarray Assay, supplied by Rosetta Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirview+mets2+64-microrna+microarray+assay/mirview+mets/pm23124598-30-13-20
Average 90 stars, based on 1 article reviews
mirview mets2 64-microrna microarray assay - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors. Article Snippet: No data exist on biologic differences between Cancer of unknown primary (CUP) and metastatic solid tumors of known primary site.. We assigned a primary tissue of origin in 40 favorable CUP patients (A: serous peritoneal carcinomatosis n = 14, B: axillary adenocarcinoma n = 8, C: upper squamous cervical adenopathy n = 18) by means of a 64-microRNA assay.. Subsequently, we profiled the expression of 733 microRNAs (miRs) in the CUP cases and compared results with metastasesfrom20ovarian carcinomas, 10 breast adenocarcinomas, 20 squamous head neck or lung tumors. |